| 000 | 01215 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516031455.0 | ||
| 264 | 0 | _c20110818 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1555-905X | ||
| 024 | 7 |
_a10.2215/CJN.01490211 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeier, Pascal | |
| 245 | 0 | 0 |
_aPlasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD. _h[electronic resource] |
| 260 |
_bClinical journal of the American Society of Nephrology : CJASN _cApr 2011 |
||
| 300 |
_a697-9 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAtherosclerosis _xetiology |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aCytokine TWEAK |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xphysiopathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xblood |
| 650 | 0 | 4 |
_aSerum Amyloid P-Component _xanalysis |
| 650 | 0 | 4 |
_aTumor Necrosis Factors _xblood |
| 773 | 0 |
_tClinical journal of the American Society of Nephrology : CJASN _gvol. 6 _gno. 4 _gp. 697-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2215/CJN.01490211 _zAvailable from publisher's website |
| 999 |
_c20710606 _d20710606 |
||